FDA takes more time for cough/cold amendment
This article was originally published in The Tan Sheet
Executive Summary
FDA pushes back the targets dates for a proposed amendment to the cough/cold monograph from June to December 2010 and a final OTC monograph rule from May to October 2010, according to the Department of Health and Human Services' semi-annual regulatory 1agenda published April 26. FDA said in August 2008 it would propose revised labeling under the current final cough/cold monograph in response to concerns about pediatric cough and cold products (2"The Tan Sheet" Aug. 25, 2008). FDA's final monograph for sunscreens emerged in 1999, but industry pressure consistently has stayed its publication
You may also be interested in...
FDA Call For Pediatric Cough/Cold Input Signals New Rule Is A Long Way Off
FDA plans to revise monograph language for over-the-counter pediatric cough/cold products, but the agency is seeking input on some basic data questions first, indicating many steps will be taken before a rule can be finalized
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.